Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs
03. Januar 2017 09:00 ET
|
Poseida Therapeutics, Inc.
SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced...